The Clinical Trials on Alzheimer's Disease conference and the Alzheimer's Drug Discovery Foundation are joining forces to launch a specialized Biotech Showcase at the 2026 CTAD gathering in Boston. The initiative aims to bridge the gap between scientific discovery and market-ready clinical development for next-generation dementia therapeutics.
The Guardian Life Insurance Company of America is expanding its employee benefits ecosystem through a partnership with XP Health, introducing a digital-first vision care platform. The collaboration aims to simplify routine eye exams and eyewear procurement for workers across 26 states by offering transparent pricing and virtual try-on tools.
As the United States approaches its 250th birthday, Busch Gardens is rolling out its largest promotional event of the year. The park operator is offering deep discounts on tickets and annual passes across its Tampa Bay and Williamsburg locations, pairing the savings with a series of patriotic events and new attractions.
Managed Health Services has launched a statewide grant initiative aimed at helping Medicaid members navigate workforce barriers. By funding local nonprofits, the program seeks to improve job placement and economic stability for residents who struggle with obstacles like limited childcare, unreliable transportation, and a lack of professional credentials.
A new immunotherapeutic for dogs, AKS-699, maintained over 80% reduction in pruritus for a full year during a head-to-head challenge study, matching the efficacy of the industry-standard lokivetmab while requiring significantly fewer injections.
Eli Lilly and Company has acquired Austin-based 4E Therapeutics, a move aimed at integrating 4E’s proprietary MNK inhibitor technology into Lilly’s neuroscience portfolio. The deal seeks to fast-track non-opioid treatments for chronic pain by disrupting specific signaling pathways within peripheral sensory neurons rather than the central nervous system.
Scissors cut through a ceremonial ribbon at 135 South Road on June 16, marking the official launch of the new Advanced Functional Fabrics of America headquarters in Bedford, Massachusetts. The facility serves as a central hub for the organization’s mission to modernize U.S. textile manufacturing and defense-related fiber technology.
Navigating the Virginia Beach real estate market requires more than just a listing; it demands a strategy tailored to the unique collision of local residents and military relocation cycles. Real estate expert Robert Ramey argues that success hinges on understanding the specific pressures driving both PCS families and local buyers.
Investors who purchased Calix, Inc. stock between January 28 and April 21, 2026, are being urged to join a class action lawsuit filed by The Gross Law Firm. The legal action centers on allegations that the company misled shareholders regarding its supply chain health and margin stability during the first quarter.
Aboard a private jet in Boca Raton, professional golfer Matthieu Pavon stepped away from the fairway to join the leadership team of V2 Jets. The photoshoot marks a strategic deepening of the partnership between the luxury aviation firm and the athlete, emphasizing shared values of precision and elite performance.
With rice cake sales surging 74 percent over the past two years, snack brand Like Air is pivoting from its signature puffcorn to a new lineup of indulgent, bite-sized rice cakes. The company is rolling out four dessert-inspired flavors across 6,000 retail locations this summer to capture the growing salty snack segment.
Investors who purchased Badger Meter, Inc. stock between April 18, 2024, and April 16, 2026, have until August 3, 2026, to seek appointment as lead plaintiff in a class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s financial health and market demand for its products during that period.
Investors who purchased FS KKR Capital Corp (FSK) stock between May 8, 2024, and February 25, 2026, have until July 6, 2026, to seek lead plaintiff status in a pending securities class action. The legal challenge centers on allegations that the company provided misleading information regarding its portfolio valuations and distribution strategies.
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, have until July 27 to petition for lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s core veterinary product performance and market share stability.
Investors who purchased Helen of Troy Limited stock between April 24, 2024, and October 8, 2025, are being urged to join a securities class action lawsuit. The filing centers on allegations that the company misled shareholders regarding the viability and expected financial impact of its internal initiative, Project Pegasus.
A 31% single-day stock collapse has triggered a securities class action lawsuit against Commvault Systems, Inc. Investors who purchased shares between April 29, 2025, and January 26, 2026, are being urged to contact The Gross Law Firm regarding potential claims before the July 17 lead plaintiff deadline.
Investors who held Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, have until July 13 to join a securities class action against the company. The lawsuit centers on allegations that the healthcare software firm misled shareholders regarding its revenue growth and pharmaceutical marketing demand.
Investors who bought SES AI Corporation stock between January 29, 2025, and March 4, 2026, are being urged to join a class action lawsuit. The Gross Law Firm claims the company misled shareholders about its growth prospects and revenue health during that period, leading to potential financial losses.
Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, have until July 27, 2026, to file for lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s competitive standing in U.S. Space Force contracts.
Investors who purchased LKQ Corporation common stock between February 27, 2023, and July 23, 2025, face an approaching deadline to join a pending class action lawsuit. The Gross Law Firm is currently seeking individuals who incurred financial losses following allegations of artificially inflated share prices caused by misleading corporate statements.
Investors who purchased Globant S.A. stock between February 15, 2024, and August 14, 2025, have until June 23, 2026, to seek lead plaintiff status in a pending securities class action. The litigation claims the software company misled shareholders regarding the stability and growth potential of its Latin American operations.
Investors who purchased Lucid Group, Inc. stock between February 25 and April 13, 2026, face a July 28 deadline to apply as lead plaintiffs in a new class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s manufacturing capabilities and supply chain stability for the Lucid Gravity model.
Investors who purchased Graphic Packaging Holding Company shares between February 4, 2025, and February 2, 2026, have until July 6, 2026, to seek lead plaintiff status in a pending class action lawsuit. The Gross Law Firm is currently organizing the case, targeting alleged misrepresentations regarding the company’s inventory and financial health.
For adults seeking to correct minor crowding without the visibility of traditional metal hardware, clear aligners have emerged as a primary alternative in Spokane. By leveraging digital planning and removable trays, these systems offer a lifestyle-friendly approach to tooth alignment, provided patients maintain the necessary daily commitment.
Investors who purchased GeneDx Holdings Corp. stock between April 16, 2025, and May 4, 2026, are being urged to join a securities class action lawsuit. The Gross Law Firm alleges that company leadership misled shareholders regarding the financial benefits and operational viability of the Fabric acquisition.
A securities class action lawsuit has been launched against PicS N.V. following allegations that the company misled investors during its January 2026 initial public offering. The Gross Law Firm is now seeking to represent shareholders who purchased Class A common stock and incurred losses due to undisclosed credit risks.
Investors who purchased Sportradar Group AG shares between November 7, 2024, and April 21, 2026, are being urged to join a class action lawsuit. The litigation targets claims that the sports data company misled shareholders regarding its regulatory compliance and relationships with illicit gambling operators.
A 50.55% single-day stock collapse following the failure of the NHS-Galleri trial has triggered a securities class action against GRAIL, Inc. Investors who purchased shares between May 13, 2025, and February 19, 2026, now face an August 4, 2026, deadline to seek appointment as lead plaintiff in the ongoing litigation.
As businesses rush to deploy autonomous AI agents, the attack surface for enterprise infrastructure has outpaced traditional defensive tools. Cybersecurity firm OffSec is responding with the Advanced AI Red Teaming course and the new OSAI certification, a 24-hour practical examination designed to test human intuition against machine logic.
Investors who purchased Regencell Bioscience Holdings Limited shares between October 28, 2024, and October 31, 2025, have until June 23, 2026, to file for lead plaintiff status. The Gross Law Firm has initiated a class action, alleging that the company misled shareholders regarding its vulnerability to market manipulation.
